{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:59:23Z","timestamp":1785513563462,"version":"3.56.0"},"reference-count":6,"publisher":"Mattioli1885","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.5826\/dpc.1603a7022","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:08:18Z","timestamp":1785510498000},"page":"7022","source":"Crossref","is-referenced-by-count":0,"title":["Factors Influencing the Treatment Response of Tetracyclines for Papulopustular Rash Induced by Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: A Retrospective Study"],"prefix":"10.5826","volume":"16","author":[{"given":"Tae Min","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Dermatology, Seoul National University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namkyu","family":"Kim","sequence":"first","affiliation":[{"name":"Seoul National University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Woo","sequence":"first","affiliation":[{"name":"Seoul National University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhumsuk","family":"Keam","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea 5Cancer Research Institute, Seoul National University, Seoul, Republic of Korea& Skin Cancer\/ Chemotherapy Skin Care Center, Seoul National University Cancer Hospital, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Su","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Dermatology, Seoul Metropolitan Government \u2013 Seoul National University (SMG-SNU) Boramae Medical Center, Seoul, Republic of Korea & Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Jin","family":"Jo","sequence":"first","affiliation":[{"name":"Department of Dermatology, Seoul National University Hospital, Seoul, Korea & Cancer Research Institute, Seoul National University, Seoul, Republic of Korea & Skin Cancer\/ Chemotherapy Skin Care Center, Seoul National University Cancer Hospital, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27750","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"10.5826\/dpc.1603a7022_ref1","doi-asserted-by":"crossref","unstructured":"Fabbrocini G, Panariello L, Caro G, Cacciapuoti S. Acneiform Rash Induced by EGFR Inhibitors: Review of the Literature and New Insights. Skin Appendage Disord. 2015;1(1):31-37. DOI:10.1159\/000371821","DOI":"10.1159\/000371821"},{"key":"10.5826\/dpc.1603a7022_ref2","doi-asserted-by":"crossref","unstructured":"Sano K, Nakadate K, Hanada K. Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptor-tyrosine kinase inhibitors for non-small cell lung cancer. BMC Cancer. 2020;20(1):279. Published 2020 Apr 6. DOI:10.1186\/s12885-020-06797-2","DOI":"10.1186\/s12885-020-06797-2"},{"key":"10.5826\/dpc.1603a7022_ref3","unstructured":"Landi L, Cappuzzo F. Irreversible EGFR-TKIs: dreaming perfection. Transl Lung Cancer Res. 2013;2(1):40-49. DOI:10.3978\/j.issn.2218-6751.2012.12.05"},{"key":"10.5826\/dpc.1603a7022_ref4","doi-asserted-by":"crossref","unstructured":"Asadi A, Abdi M, Kouhsari E, et al. Minocycline, focus on mechanisms of resistance, antibacterial activity, and clinical effectiveness: Back to the future. J Glob Antimicrob Resist. 2020;22:161-174. DOI:10.1016\/j.jgar.2020.01.022","DOI":"10.1016\/j.jgar.2020.01.022"},{"key":"10.5826\/dpc.1603a7022_ref5","doi-asserted-by":"crossref","unstructured":"Carris NW, Pardo J, Montero J, Shaeer KM. Minocycline as A Substitute for Doxycycline in Targeted Scenarios: A Systematic Review. Open Forum Infect Dis. 2015;2(4):ofv178. Published 2015 Nov 25. DOI:10.1093\/ofid\/ofv178","DOI":"10.1093\/ofid\/ofv178"},{"key":"10.5826\/dpc.1603a7022_ref6","doi-asserted-by":"crossref","unstructured":"Modheji M, Olapour S, Khodayar MJ, Jalili A, Yaghooti H. Minocycline is more potent than tetracycline and doxycycline in inhibiting MMP-9 in vitro. 2016. DOI: 10.17795\/jjnpp-27377","DOI":"10.17795\/jjnpp-27377"}],"container-title":["Dermatology Practical & Conceptual"],"original-title":[],"link":[{"URL":"https:\/\/dpcj.org\/index.php\/dpc\/article\/download\/7022\/3935","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dpcj.org\/index.php\/dpc\/article\/download\/7022\/3935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:08:19Z","timestamp":1785510499000},"score":1,"resource":{"primary":{"URL":"https:\/\/dpcj.org\/index.php\/dpc\/article\/view\/7022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":6,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5826\/dpc.1603a7022","relation":{"has-manifestation":[{"id-type":"other","id":"1-84-7022-g3935","asserted-by":"subject"}],"is-part-of":[{"id-type":"doi","id":"10.5826\/dpc.1603a%a","asserted-by":"subject"}]},"ISSN":["2160-9381"],"issn-type":[{"value":"2160-9381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"article-number":"23"}}